HealthWarehouse.com Inc (HEWA)
OTHER OTC:HEWA
Want to see HEWA full AI Analyst Report?
HEWA Stock Chart & Stats
$0.12
<$0.01(0.61%)
At close: 4:00 PM EST
$0.12
<$0.01(0.61%)
Day’s Range― - ―
52-Week Range$0.08 - $0.18
Previous CloseN/A
Volume49.90K
Average Volume (3M)2.08K
Market Cap
$4.16M
Enterprise Value$4.96M
Total Cash (Recent Filing)$2.21M
Total Debt (Recent Filing)$2.90M
Price to Earnings (P/E)23.4
Beta-0.56
Next Earnings
May 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding42,649,000
10 Day Avg. Volume2,307
30 Day Avg. Volume2,084
Financial Highlights & Ratios
PEG Ratio-0.26
Price to Book (P/B)-1.88
Price to Sales (P/S)0.13
P/FCF Ratio5.83
Enterprise Value/Market Cap1.19
Enterprise Value/Revenue0.10
Enterprise Value/Gross Profit0.29
Enterprise Value/Ebitda5.23
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improved Cash GenerationPositive operating cash flow (~$1.2M) and free cash flow (~$1.1M) in 2025 indicate the core pharmacy operations can generate internal liquidity. Durable cash generation reduces near-term financing need, supports working capital and targeted reinvestment, and strengthens earnings quality versus paper profits.
Profitability Turnaround In 2025Transition from multi-year losses to a small net profit ($0.3M) in 2025 demonstrates the business can reach profitability at current scale. This structural improvement validates cost control and pricing execution, making future margin expansion or reinvestment more feasible if the company sustains these operational gains.
Direct-to-consumer Mail-order ModelA mail-order, direct-to-consumer pharmacy model concentrates fulfillment and distribution advantages around home delivery and dispensing economics. These operational characteristics can produce durable unit economics and differentiation versus traditional retail pharmacies if the company maintains acquisition and fulfillment efficiencies.
Bears Say
Negative Stockholders' EquityNegative stockholders' equity (~ -$3.3M) is a fundamental capital-structure weakness. It constrains financial flexibility, limits access to traditional financing, increases creditor and investor scrutiny, and raises the risk of dilution or covenant pressure if operating performance backslides, hindering long-term strategic options.
Very Thin Profitability And Revenue DropExtremely thin margins (net ~0.5%, operating <1%) combined with a ~7% revenue decline in 2025 limit the firm's ability to self-fund growth or absorb cost inflation. Structurally low profitability reduces buffers against reimbursement pressure and makes meaningful margin expansion necessary for durable financial health.
Cash Flow Volatility And Weak ConversionFree cash flow volatility (a ~55% decline year-over-year) and operating cash flow that is small relative to revenue indicate weak cash conversion. This undermines consistent reinvestment capacity, raises financing needs during downturns, and increases execution risk for sustaining growth or deleveraging over the medium term.
HEWA FAQ
What was HealthWarehouse.com Inc’s price range in the past 12 months?
HealthWarehouse.com Inc lowest stock price was $0.08 and its highest was $0.18 in the past 12 months.
What is HealthWarehouse.com Inc’s market cap?
HealthWarehouse.com Inc’s market cap is $4.16M.
When is HealthWarehouse.com Inc’s upcoming earnings report date?
HealthWarehouse.com Inc’s upcoming earnings report date is May 07, 2026 which is in 7 days.
How were HealthWarehouse.com Inc’s earnings last quarter?
HealthWarehouse.com Inc released its earnings results on Mar 20, 2026. The company reported -$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.003.
Is HealthWarehouse.com Inc overvalued?
According to Wall Street analysts HealthWarehouse.com Inc’s price is currently Overvalued.
Does HealthWarehouse.com Inc pay dividends?
HealthWarehouse.com Inc does not currently pay dividends.
What is HealthWarehouse.com Inc’s EPS estimate?
HealthWarehouse.com Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HealthWarehouse.com Inc have?
HealthWarehouse.com Inc has 42,649,000 shares outstanding.
What happened to HealthWarehouse.com Inc’s price movement after its last earnings report?
HealthWarehouse.com Inc reported an EPS of -$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of HealthWarehouse.com Inc?
Currently, no hedge funds are holding shares in HEWA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
HealthWarehouse.com Inc
HealthWarehouse.com, Inc. operates an online and mail order pharmacy. The company markets a range of generic, brand name, and pet prescription medicines, as well as over-the-counter (OTC) medications and products. It sells its products in 50 states and the District of Columbia in the United States to focus on the out-of-pocket prescription drug market. The company sells prescription medications and OTC products to individual consumers over the Internet. HealthWarehouse.com, Inc. is headquartered in Florence, Kentucky.
Technical Analysis
Petmed Express
―
ENDRA Life Sciences
―
LifeMD
―
Pasithea Therapeutics Corp
―
Heart Test Laboratories, Inc.
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.02% Other Institutional Investors
99.98% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---